Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HSRYV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DM005
|
|||||
| Synonyms |
DM-005; DM 005; DM005
Click to Show/Hide
|
|||||
| Organization |
Doma Biopharmaceutical (Suzhou) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 3 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Hepatocyte growth factor receptor (MET); Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
BCPT02
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
| Combination Type |
BLD1102
|
|||||
